Inhaled Corticosteroids and the Risk of Lung Cancer in Chronic Obstructive Pulmonary Disease Patients: A Systematic Review and Meta-Analysis
Background. The global prevalence of chronic obstructive pulmonary disease (COPD) is increasing, and the risk of lung cancer in these patients is high. The use of inhaled corticosteroids (ICSs) in COPD patients could help to decrease potential lung cancer risk. We planned to conduct this systematic...
Saved in:
Main Authors: | Amare Abera Tareke, Wondwosen Debebe, Addis Alem, Nebiyou Simegnew Bayileyegn, Taddese Alemu Zerfu, Andualem Mossie Ayana |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Pulmonary Medicine |
Online Access: | http://dx.doi.org/10.1155/2022/9799858 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhaled corticosteroids in asthma and chronic obstructive pulmonary disease combined phenotype: when to use and what to expect?
by: Srishankar Bairy, et al.
Published: (2025-01-01) -
Inhaled Corticosteroid Therapy Does Not Control Asthma
by: Robert L Cowie, et al.
Published: (2004-01-01) -
Chronic Obstructive Pulmonary Disease Patients With Community‐Acquired Pneumonia on Inhaled Corticosteroid Therapy: A Comprehensive Analysis of Risk Factors, Disease Burden, and Prevention Strategies
by: Muhammad Muneeb Hassan, et al.
Published: (2025-01-01) -
Osteonecrosis of the Femoral Head in an Adolescent on Long-Term Inhalational Corticosteroids
by: Anthony C. Egger, et al.
Published: (2017-01-01) -
Montelukast as Add-On Therapy with Inhaled Corticosteroids or Inhaled Corticosteroids and Long-Acting Beta-2-Agonists in the Management of Patients Diagnosed with Asthma and Concurrent Allergic Rhinitis (The RADAR Trial)
by: Paul K Keith, et al.
Published: (2009-01-01)